A new market study, titled “Global Insulin Drug and Delivery Technologies Market Research Report 2019” has been featured on WiseGuyReports.
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
The global Insulin Drug and Delivery Technologies market is valued at 36000 million US$ in 2018 is expected to reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
This report focuses on Insulin Drug and Delivery Technologies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Drug and Delivery Technologies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Request Free Sample Report at https://www.wiseguyreports.com/sample-request/3825998-global-insulin-drug-and-delivery-technologies-market-research-report-2019
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Table of Contents
Executive Summary
1 Insulin Drug and Delivery Technologies Market Overview
2 Global Insulin Drug and Delivery Technologies Market Competition by Manufacturers
3 Global Insulin Drug and Delivery Technologies Production Market Share by Regions
4 Global Insulin Drug and Delivery Technologies Consumption by Regions
5 Global Insulin Drug and Delivery Technologies Production, Revenue, Price Trend by Typ
6 Global Insulin Drug and Delivery Technologies Market Analysis by Applications
7 Company Profiles and Key Figures in Insulin Drug and Delivery Technologies Business
8 Insulin Drug and Delivery Technologies Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Global Insulin Drug and Delivery Technologies Market Forecast
12 Research Findings and Conclusion
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
